Pharmathen provides life cycle Management solutions for branded pharma, as well as to develop & establish new technology platforms.
01 2Pharmathen SA
02 3APGDI
03 2Alkem Laboratories
04 2Apotex Inc
05 19Astellas Pharma
06 1Aurobindo Pharma Limited
07 2Cipla Medpro South Africa
08 2KMS Health Center
09 2Lupin Ltd
10 2Qilu Pharmaceutical
11 2Sawai Pharmaceutical Co
12 2Tecnimede
13 2Unichem Laboratories Limited
14 1Whanin Pharmaceutical
15 2Zydus Pharmaceuticals
01 4Depot tablet
02 5Depottablett
03 2ER Tablet
04 2FCT
05 1FOR SUSPENSION, EXTENDED RELEASE;ORAL
06 2PROLONGED-RELEASE TABLET
07 2Prolonged Release Tablet
08 2Prolonged Release Tablets
09 4Ret Tablet
10 2TAB
11 2TABLET (EXTENDED-RELEASE)
12 2TABLET, EXTENDED RELEASE
13 13TABLET, EXTENDED RELEASE;ORAL
14 3Tablet
01 1DISCN
02 6Generic
03 2Originator
04 2Prescription
05 12RX
06 23Blank
01 1Bemiga SR
02 15Betmiga
03 1Betmiga 25 mg
04 1Betmiga 50 mg
05 13MIRABEGRON
06 4MYRBETRIQ
07 1MYRBETRIQ GRANULES
08 1Urton 25
09 1Urton 50
10 8Blank
01 2Canada
02 2Greece
03 4India
04 9Norway
05 2Portugal
06 4South Africa
07 1South Korea
08 2Sweden
09 4Switzerland
10 16USA
Pharmathen provides life cycle Management solutions for branded pharma, as well as to develop & establish new technology platforms.
Regulatory Info :
Registration Country : Greece
Brand Name :
Dosage Form : Prolonged Release Tablet
Dosage Strength : 25MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Greece
Pharmathen provides life cycle Management solutions for branded pharma, as well as to develop & establish new technology platforms.
Regulatory Info :
Registration Country : Greece
Brand Name :
Dosage Form : Prolonged Release Tablet
Dosage Strength : 50MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Greece
Regulatory Info : RX
Registration Country : USA
Brand Name : MIRABEGRON
Dosage Form : TABLET, EXTENDED RELEASE;ORAL
Dosage Strength : 25MG
Packaging :
Approval Date : 2024-02-12
Application Number : 215948
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : MIRABEGRON
Dosage Form : TABLET, EXTENDED RELEASE;ORAL
Dosage Strength : 50MG
Packaging :
Approval Date : 2024-02-12
Application Number : 215948
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : MYRBETRIQ
Dosage Form : TABLET, EXTENDED RELEASE;ORAL
Dosage Strength : 25MG
Packaging :
Approval Date : 2012-06-28
Application Number : 202611
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : MYRBETRIQ
Dosage Form : TABLET, EXTENDED RELEASE;ORAL
Dosage Strength : 50MG
Packaging :
Approval Date : 2012-06-28
Application Number : 202611
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : MYRBETRIQ GRANULES
Dosage Form : FOR SUSPENSION, EXTENDED RELEASE;ORAL
Dosage Strength : 8MG/ML
Packaging :
Approval Date : 2021-03-25
Application Number : 213801
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : MIRABEGRON
Dosage Form : TABLET, EXTENDED RELEASE;ORAL
Dosage Strength : 25MG
Packaging :
Approval Date : 2025-01-02
Application Number : 209434
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : MIRABEGRON
Dosage Form : TABLET, EXTENDED RELEASE;ORAL
Dosage Strength : 50MG
Packaging :
Approval Date : 2025-01-02
Application Number : 209434
Regulatory Info : RX
Registration Country : USA
Regulatory Info :
Registration Country : Sweden
Brand Name : Betmiga
Dosage Form : PROLONGED-RELEASE TABLET
Dosage Strength : 50 MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Sweden
Regulatory Info :
Registration Country : Sweden
Brand Name : Betmiga
Dosage Form : PROLONGED-RELEASE TABLET
Dosage Strength : 25 MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Sweden
Regulatory Info :
Registration Country : USA
Brand Name : MIRABEGRON
Dosage Form : TABLET, EXTENDED RELEASE;ORAL
Dosage Strength : 50MG
Packaging :
Approval Date :
Application Number : 209413
Regulatory Info :
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : MIRABEGRON
Dosage Form : TABLET, EXTENDED RELEASE;ORAL
Dosage Strength : 25MG
Packaging :
Approval Date : 2022-09-28
Application Number : 209485
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : MIRABEGRON
Dosage Form : TABLET, EXTENDED RELEASE;ORAL
Dosage Strength : 50MG
Packaging :
Approval Date : 2022-09-28
Application Number : 209485
Regulatory Info : RX
Registration Country : USA
Regulatory Info :
Registration Country : USA
Brand Name : MIRABEGRON
Dosage Form : TABLET, EXTENDED RELEASE
Dosage Strength : 50MG
Packaging :
Approval Date :
Application Number : 217989
Regulatory Info :
Registration Country : USA
Regulatory Info :
Registration Country : USA
Brand Name : MIRABEGRON
Dosage Form : TABLET, EXTENDED RELEASE
Dosage Strength : 25MG
Packaging :
Approval Date :
Application Number : 217989
Regulatory Info :
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : MIRABEGRON
Dosage Form : TABLET, EXTENDED RELEASE;ORAL
Dosage Strength : 25MG
Packaging :
Approval Date : 2019-12-27
Application Number : 209446
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : MIRABEGRON
Dosage Form : TABLET, EXTENDED RELEASE;ORAL
Dosage Strength : 50MG
Packaging :
Approval Date : 2025-05-06
Application Number : 217061
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : MIRABEGRON
Dosage Form : TABLET, EXTENDED RELEASE;ORAL
Dosage Strength : 25MG
Packaging :
Approval Date : 2022-09-29
Application Number : 209488
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : MIRABEGRON
Dosage Form : TABLET, EXTENDED RELEASE;ORAL
Dosage Strength : 50MG
Packaging :
Approval Date : 2022-09-29
Application Number : 209488
Regulatory Info : RX
Registration Country : USA
